BODE Index Calculator — COPD Mortality & Severity Assessment
The BODE Index is a multidimensional grading system that predicts mortality in patients with chronic obstructive pulmonary disease (COPD). It combines four variables: body mass index (BMI), degree of airflow obstruction (FEV1), dyspnea severity (MMRC), and exercise capacity (6-minute walk distance). The index provides superior prognostic information compared to FEV1 alone.
About
The BODE Index (BMI, Obstruction, Dyspnea, Exercise) was developed by Celli et al. in 2004 to address the limitation of using FEV1 alone for COPD prognostication. It integrates four distinct domains of COPD impact: nutritional status (BMI), pulmonary function (FEV1 % predicted), symptom burden (MMRC dyspnea scale), and functional capacity (6-minute walk distance). Each domain contributes 0-3 points (BMI 0-1), yielding a total score of 0-10. Higher scores indicate greater disease severity and higher mortality risk. The BODE Index has been validated in multiple populations and is recommended by GOLD for comprehensive COPD assessment.
Formula
BODE Index = BMI Score (0-1) + FEV1 Score (0-3) + MMRC Score (0-3) + 6MWD Score (0-3)
The BODE Index assigns points based on four variables: BMI >21 = 0 points, ≤21 = 1 point. FEV1 ≥65% = 0, 50-64% = 1, 36-49% = 2, ≤35% = 3. MMRC 0-1 = 0, 2 = 1, 3 = 2, 4 = 3. 6-minute walk distance ≥350m = 0, 250-349m = 1, 150-249m = 2, ≤149m = 3. Total score ranges from 0-10.
Score Interpretation
The BODE Index is one of the most important prognostic tools in COPD management. It provides a more comprehensive assessment than FEV1 alone by incorporating nutritional status, symptom burden, and functional capacity. The index predicts mortality, hospitalization risk, and quality of life outcomes. Each 1-point increase in BODE score is associated with an increased risk of death (hazard ratio 1.34). A change of 1-2 points is considered the minimal clinically important difference.
Mild — 0–2
BODE Index 0-2. Lowest mortality risk. Good functional status.
Management: Routine COPD management, annual monitoring, encourage physical activity.
Moderate — 3–4
BODE Index 3-4. Moderate mortality risk. Some functional limitation.
Management: Optimize bronchodilator therapy, pulmonary rehabilitation, monitor every 3-6 months.
Severe — 5–6
BODE Index 5-6. High mortality risk. Significant functional limitation.
Management: Triple therapy, pulmonary rehabilitation, assess for oxygen therapy, monitor every 1-3 months.
Very Severe — 7–10
BODE Index 7-10. Very high mortality risk. Severe functional limitation.
Management: Multidisciplinary care, long-term oxygen, evaluate for lung volume reduction or transplant, palliative care.
Reference Ranges
| Population | Normal Range | Notes |
|---|---|---|
| COPD patients | 0-10 | Higher scores indicate worse prognosis |
Dr. Khaled Hassan
Dr. Khaled is a cardiology consultant with experience in acute cardiac care.
View medical review board & editorial policy →Example Calculation
A 68-year-old man with COPD: BMI 22 (>21 = 0), FEV1 38% predicted (36-49% = 2), MMRC 3 (= 2), 6MWD 180m (150-249 = 2). BODE = 0 + 2 + 2 + 2 = 6 (severe, high mortality risk).
Related Conditions
Common Mistakes
Using BODE Index for asthma patients
The BODE Index was validated specifically for COPD patients, not asthma. Use asthma-specific tools like ACT or GINA criteria.
Not using the most recent values for each component
All four components should be measured within a short time frame (preferably the same clinical encounter) for accurate scoring.
Frequently Asked Questions
What is the advantage of BODE over FEV1 alone?
How often should BODE Index be reassessed?
References
- Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-1012. PubMed
- GOLD 2024 Strategy Report for Diagnosis, Management, and Prevention of COPD